retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide The power of three: Retatrutide's role in modern obesity and diabetes therapy 🚨 HOT OFF THE PRESS:

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

That means it needs strict temperature control, precise manufacturing, and no contamination

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.

A systematic search of PubMed, Scopus, and Web of Science was conducted up to December 2024 according to PRISMA guidelines